Alligator Bioscience is ready for an exciting news flow
A lot is going on at Alligator Bioscience. CEO Søren Bregenholt visited BioStock’s studio to talk about the news flow expected in the coming months. He commented on updated study plans and is excited about clinical trial read outs, as well as progress in the pipeline and in collaborations. Bregenholt is also looking forward to updating markets about the advanced and structured partnership discussions that Alligator is involved in.
Watch the interview with Alligator Bioscience’s CEO Søren Bregenholt in the link below.
Innehållet i BioStocks nyheter och analyser är oberoende men BioStocks verksamhet är i viss mån finansierad av bolag i branschen. Detta inlägg avser ett bolag som BioStock erhållit finansiering från.
